Alpex Acquisition Corporation (NASDAQ: ALPXU) announced the closing of its initial public offering of 11.5 million units, including the full exercise of the underwriters’ over-allotment option, generating gross proceeds of $115 million before expenses. The units began trading on the Nasdaq Global Market on June 25 under the ticker “ALPXU,” according to a company press release.
Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon completion of an initial business combination. Concurrently with the IPO, the company completed a private placement of 187,500 units that raised an additional $1.875 million in gross proceeds.
Alpex said $115 million of the net proceeds from the public offering and private placement has been placed in trust, with an audited balance sheet to be included in a forthcoming Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission. The trust funds are intended to be used to complete a business combination, typically a merger, share exchange, asset acquisition, or similar transaction.
As a special purpose acquisition company (SPAC), Alpex Acquisition Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Notably, the company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, giving it broad flexibility in seeking a deal.
The successful IPO and concurrent private placement provide Alpex with significant capital to pursue a target. The $115 million in trust, combined with any additional financing or sponsor support, positions the company to potentially acquire a high-growth business. For investors, SPACs offer a way to participate in private equity-like investments with public market liquidity, though they carry risks including the possibility that no suitable target is found within the allotted timeframe.
Alpex’s IPO comes amid a fluctuating SPAC market, where regulatory scrutiny and market conditions have affected the pace of new offerings. However, the full exercise of the over-allotment option indicates strong demand from investors. The company will now focus on identifying and negotiating with potential target companies, with the goal of completing a business combination within the typical 18-24 month window.
For more details, the full announcement is available at https://ibn.fm/3xTGJ.
